These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 3102302

  • 1. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.
    Koike T, Itoh Y, Ishii T, Ito I, Takabayashi K, Maruyama N, Tomioka H, Yoshida S.
    Diabetes; 1987 Apr; 36(4):539-41. PubMed ID: 3102302
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent.
    Wang Y, Hao L, Gill RG, Lafferty KJ.
    Diabetes; 1987 Apr; 36(4):535-8. PubMed ID: 3102301
    [Abstract] [Full Text] [Related]

  • 3. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.
    Miller BJ, Appel MC, O'Neil JJ, Wicker LS.
    J Immunol; 1988 Jan 01; 140(1):52-8. PubMed ID: 3275717
    [Abstract] [Full Text] [Related]

  • 4. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin.
    Herold KC, Montag AG, Fitch FW.
    Diabetes; 1987 Jul 01; 36(7):796-801. PubMed ID: 3556279
    [Abstract] [Full Text] [Related]

  • 5. Progression from insulitis to beta-cell destruction in NOD mouse requires L3T4+ T-lymphocytes.
    Charlton B, Mandel TE.
    Diabetes; 1988 Aug 01; 37(8):1108-12. PubMed ID: 3292330
    [Abstract] [Full Text] [Related]

  • 6. Generation of L3T4-/Ly-2- T cells in Peyer's patches of mice treated with monoclonal antibody against helper T cells.
    Ermak TH, Steger HJ, Heyworth MF.
    Immunol Lett; 1988 Mar 01; 17(3):205-10. PubMed ID: 2897329
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
    Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintáns J, Loken MR, Pierres M, Fitch FW.
    J Immunol; 1983 Nov 01; 131(5):2445-51. PubMed ID: 6415170
    [Abstract] [Full Text] [Related]

  • 8. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.
    Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG.
    Science; 1988 Apr 29; 240(4852):659-62. PubMed ID: 2966437
    [Abstract] [Full Text] [Related]

  • 9. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL, Havran WL, Nau GJ, Lancki DW, Kim DK, Fitch FW.
    J Immunol; 1987 Aug 01; 139(3):657-64. PubMed ID: 2955046
    [Abstract] [Full Text] [Related]

  • 10. L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice.
    Kantwerk G, Cobbold S, Waldmann H, Kolb H.
    Clin Exp Immunol; 1987 Dec 01; 70(3):585-92. PubMed ID: 2963718
    [Abstract] [Full Text] [Related]

  • 11. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J, Schurmans S, Luzuy S, Izui S, Vassalli P, Lambert PH.
    J Immunol; 1987 Sep 01; 139(5):1426-31. PubMed ID: 3114366
    [Abstract] [Full Text] [Related]

  • 12. Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD/Shi/Kbe mice by anti-MHC class I Kd monoclonal antibody.
    Taki T, Nagata M, Ogawa W, Hatamori N, Hayakawa M, Hari J, Shii K, Baba S, Yokono K.
    Diabetes; 1991 Sep 01; 40(9):1203-9. PubMed ID: 1936625
    [Abstract] [Full Text] [Related]

  • 13. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL, Wheelahan J, McKenzie IF, Clunie GJ.
    Transplant Proc; 1987 Apr 01; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract] [Full Text] [Related]

  • 14. Short-term administration of anti-L3T4 MoAb prevents diabetes in NOD mice.
    Kurasawa K, Sakamoto A, Maeda T, Sumida T, Ito I, Tomioka H, Yoshida S, Koike T.
    Clin Exp Immunol; 1993 Mar 01; 91(3):376-80. PubMed ID: 8095192
    [Abstract] [Full Text] [Related]

  • 15. Induction of insulitis by adoptive transfer with L3T4+Lyt2- T-lymphocytes in T-lymphocyte-depleted NOD mice.
    Hanafusa T, Sugihara S, Fujino-Kurihara H, Miyagawa J, Miyazaki A, Yoshioka T, Yamada K, Nakajima H, Asakawa H, Kono N.
    Diabetes; 1988 Feb 01; 37(2):204-8. PubMed ID: 3292315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K, Jönsson JI, Falk I, Emmrich F.
    Eur J Immunol; 1987 May 01; 17(5):643-50. PubMed ID: 3108015
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.
    Titus RG, Ceredig R, Cerottini JC, Louis JA.
    J Immunol; 1985 Sep 01; 135(3):2108-14. PubMed ID: 3926895
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression.
    Dumont FJ.
    J Immunol; 1987 Jun 15; 138(12):4106-13. PubMed ID: 2438334
    [Abstract] [Full Text] [Related]

  • 20. Prolongation of islet isograft survival in diabetic NOD mice by anti-L3T4 and anti-LYT2 monoclonal antibodies.
    Matsuo S, Mullen Y, Wicker LS, Peterson LB, Nagata M, Tsunoda T, Clare-Salzler M.
    Transplant Proc; 1990 Apr 15; 22(2):880-1. PubMed ID: 2109427
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.